Summary
In 1873, Hansen discovered Mycobacterium leprae, the bacterium responsible for leprosy. While leprosy is rare in the United States, Brazil and the Indian subcontinent account for most global cases [1]. Notably, within the U.S., California and Hawaii report the most cases, predominantly among immigrants from Mexico, Asia, Africa, and the Pacific Islands [2].
 In 1873, Hansen discovered Mycobacterium leprae, the bacterium responsible for leprosy. While leprosy is rare in the United States, Brazil and the Indian subcontinent account for most global cases [1]. Notably, within the U.S., California and Hawaii report the most cases, predominantly among immigrants from Mexico, Asia, Africa, and the Pacific Islands [2].
Staining and Microbiologic features:
- M. leprae is an acid-fast organism because the abundance of lipids in its cell wall prevents decolorization by acid or alcohol during the staining process [3].
- It cannot be successfully cultured in artificial media [4].
Virulence:Â
- M. lepare lacks motility and exhibits facultative intracellular growth [5].
- It has devised mechanisms to resist lysosomal enzyme action [6].
- It tests positive for catalase and phenolase [5]
- It exhibits optimum growth at low temperatures [5].
Transmission:Â
Leprosy transmission occurs through person-to-person contact (via airborne respiratory droplets or skin contact with secretions from infected individuals) [2].
Diseases and Complications:
- Tuberculoid leprosy/Paucibacillary Hansen disease: It is a relatively milder form of the disease that occurs when the body elicits a robust cell-mediated immune response against the bacteria. The patient can present with a few well-demarcated, hairless, hypopigmented/erythematous skin lesions.
File:Paucibacillary leprosy (PB).jpg by mayrabcm is licensed under CC BY-SA 4.0.
Nerve involvement leads to decreased sensation or complete loss of sensation in extremities and the enlargement of nerves. The patient is noninfectious, and lepromin skin testing will yield a strongly positive result. Immunoglobulins are within the normal range, erythema nodosum is absent, and histopathological examination of skin scrapings will not reveal acid-fast bacilli. [2,7,8]
- Lepromatous leprosy/Multibacillary Hansen disease: It is a severe form of the disease, occurring when the cell-mediated immune response against M. leprae is impaired, possibly due to defective T suppressor cells inhibiting the T helper cells’ response to the bacterium. Patients present with widespread lesions, and potential clinical manifestations include leonine facies, saddle nose deformity, and glove-and-stocking peripheral neuropathy. The patient is highly infectious, and lepromin skin testing will yield a negative result. Immunoglobulin levels are high, erythema nodosum may be present, and histopathological examination of skin scrapings will reveal numerous acid-fast bacilli. Testicular involvement can lead to infertility, ocular involvement can result in blindness, and the condition can be fatal if left untreated [8,9].
File:Lepromatous leprosy.jpg by Dr. Roshan Nasimudeen is licensed under CC BY-SA 3.0.
Diagnostic Testing:Â
- Ziehl-Neelsen staining of the specimen [1]
Mycobacterium leprae in Ziehl-Neelsen stained smear of sputum by Ajay Kumar Chaurasiya is licensed under CC BY-SA 4.0.
- In lepromatous leprosy, acid-fast bacilli can be observed in biopsies of affected regions, whereas granulomas are present in the case of tuberculoid leprosy [10].
 References:
- Jawetz, Melnick, & Adelberg’s Medical Microbiology Twenty-Seventh Edition (page no: 319)
- Medical Microbiology by Patrick R. Murray Ph.D., Ken Rosenthal Ph.D., Michael A. Pfaller MD, 8th edition (page no: 225)
- Jawetz, Melnick, & Adelberg’s Medical Microbiology Twenty-Seventh Edition (page no: 309)
- CMMRS edition 6, 2016-17 (page no: 147)
- CMMRS edition 6, 2016-17 (page no: 152)
- Medical Microbiology by Patrick R. Murray Ph.D., Ken Rosenthal Ph.D., Michael A. Pfaller MD, 8th edition (page no: 141)
- CMMRS edition 6, 2016-17 (page no: 149)
- Medical Microbiology by Patrick R. Murray Ph.D., Ken Rosenthal Ph.D., Michael A. Pfaller MD, 8th edition (page no: 226)
- CMMRS edition 6, 2016-17 (page no: 148)
- CMMRS edition 6, 2016-17 (page no: 153)